Garcia Peter S (CIK 0001188956)

Latest company ownership

Shares held
207,000
Last filed at
Feb 22, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q1 2025Q4
Shares held
121,516
Last filed at
Aug 16, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 14, 2024 Aug 16, 2024 ALX ONCOLOGY HOLDINGS INC CFO Sell 37.5 -761 -0.62% ✗ $2K
Jun 28, 2024 Jul 2, 2024 ALX ONCOLOGY HOLDINGS INC CFO Sell 26.3 -1,789 -1.44% ✗ $10.8K
Jun 13, 2024 Jun 24, 2024 ALX ONCOLOGY HOLDINGS INC CFO Buy 95.0 +12,000 10.87% ✗ $102.3K
Jun 13, 2024 Jun 17, 2024 ALX ONCOLOGY HOLDINGS INC CFO Buy 95.0 +12,000 10.87% ✗ $102.3K
Dec 29, 2023 Jan 3, 2024 ALX ONCOLOGY HOLDINGS INC CFO Sell 26.3 -1,893 -2.17% ✗ $28.5K
Jun 30, 2023 Jul 5, 2023 ALX ONCOLOGY HOLDINGS INC CFO Sell 27.5 -887 -1.59% ✗ $6.5K
Dec 29, 2022 Jan 3, 2023 ALX ONCOLOGY HOLDINGS INC CFO Sell 27.5 -893 -1.64% ✗ $9.9K
Oct 18, 2021 Oct 19, 2021 ALX ONCOLOGY HOLDINGS INC CFO Sell 7.5 -7,229 -43.65% ✓ $400.8K
Sep 16, 2021 Sep 17, 2021 ALX ONCOLOGY HOLDINGS INC CFO Sell 15.0 -12,771 -15.08% ✓ $1M
Aug 23, 2021 Aug 24, 2021 ALX ONCOLOGY HOLDINGS INC CFO Sell 5.0 -60,000 -86.54% ✓ $4.4M
Aug 17, 2021 Aug 18, 2021 ALX ONCOLOGY HOLDINGS INC CFO Sell 7.5 -10,000 -51.73% ✓ $662.3K
Jul 21, 2020 Jul 21, 2020 ALX ONCOLOGY HOLDINGS INC CFO Buy 95.0 +3,000 100.00% ✗ $57K
Mar 19, 2012 Mar 19, 2012 Lineage Cell Therapeutics, Inc. CFO Buy 91.3 +5,000 250.00% ✗ $23.4K